Intensive research focuses on optimizing the use of vaccine adjuvants to not only enhance, but orientate specific Th1 or Th2 adaptive immune responses to antigens. The COVID-19 pandemic has scientists developing novel life-saving treatments at breakneck speed.
Sartorius provides innovative high-throughput & automated solutions for faster vaccine discovery, characterization & development. Our groundbreaking Octet®, iQue® and Incucyte® advanced cell & protein analysis platforms provide insights at unprecedented speed, depth & scale, streamlining workflows to accelerate results - when it counts.
Read the full publication.
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.